This healthcare solutions provider develops treatment planning software and devices for brachytherapy, a form of cancer radiotherapy that involves implanting radioactive sources directly into tumors. The company's primary product is FTTPS, a treatment planning system designed to help clinicians determine target volumes, prescription doses, and organ protection protocols for brachytherapy procedures across various malignant tumors. The software generates dose distribution plans to optimize treatment outcomes while minimizing exposure to healthy tissue.
Based in Beijing, China, iTonic operates as a subsidiary of ZJW (BVI) LTD. The company maintains a small operational footprint with approximately ten full-time employees. Originally established in 1998 under the name Pheton Holdings Ltd, the company rebranded to iTonic Holdings Ltd in January 2026. iTonic is listed on Nasdaq and primarily serves the oncology market through its brachytherapy planning and delivery solutions.
No 10-K filings found.